IPA-containing painkillers likely to be pulled from shelves

Best-selling painkillers, Samjin Pharm's Geworin, Bayer Korea's Saridon-A and others, will face being banned in the domestic market as the Korea Food and Drug Administration (KFDA) on Tuesday ordered the manufacturers to submit the safety report on isopropylantipyrine (IPA) until March next year after completion of a pilot study to evaluate pharmacokinetics of IPA.

However, given that the sa...